Toshiharu Sakurai

J-GLOBAL         Last updated: Feb 23, 2018 at 14:33
 
Avatar
Name
Toshiharu Sakurai
Affiliation
Kindai University
Section
Faculty of Medicine
Research funding number
90397539

Research Areas

 
 

Academic & Professional Experience

 
2004
   
 
Assistant Professor, Kyoto University
 

Published Papers

 
Hagiwara S, Nishida N, Watanabe T, Ida H, Sakurai T, Ueshima K, Takita M, Komeda Y, Nishijima N, Osaki Y, Kudo M
Antiviral therapy      Feb 2018   [Refereed]
Kamata K, Takenaka M, Omoto S, Miyata T, Minaga K, Yamao K, Imai H, Sakurai T, Nishida N, Chikugo T, Chiba Y, Matsumoto I, Takeyama Y, Kudo M
Gastrointestinal endoscopy   87(1) 158-163   Jan 2018   [Refereed]
Nishiyama H, Nagai T, Kudo M, Okazaki Y, Azuma Y, Watanabe T, Goto S, Ogata H, Sakurai T
Biochemical and biophysical research communications   495(1) 273-279   Jan 2018   [Refereed]
Yamao K, Kitano M, Takenaka M, Minaga K, Sakurai T, Watanabe T, Kayahara T, Yoshikawa T, Yamashita Y, Asada M, Okabe Y, Hanada K, Chiba Y, Kudo M
Gastrointestinal endoscopy      Jan 2018   [Refereed]
Kono M, Komeda Y, Sakurai T, Okamoto A, Minaga K, Kamata K, Hagiwara S, Inoue H, Enoki E, Matsumura I, Watanabe T, Kudo M
Journal of Crohn's & colitis      Dec 2017   [Refereed]

Misc

 
ARIZUMI Tadaaki, UESHIMA Kazuomi, TAKEDA Haruhiko, OSAKI Yukio, HAGIWARA Satoru, INOUE Tatsuo, KITAI Satoshi, YADA Norihisa, SAKURAI Toshiharu, NISHIDA Naoshi, KUDO Masatoshi
Kanzo   53(6) 344-347   Jun 2012
Response Evaluation Criteria In Solid Tumor version 1.1 (RECIST1.1), modified RECIST (mRECIST) and Response Evaluation Criteria In Cancer of the Liver (RECICL) are frequently used as a response evaluation criteria for hepatocellular carcinoma. The...
ARIZUMI Tadaaki, UESHIMA Kazuomi, HAYAISHI Sousuke, TAKITA Masahiro, KITAI Satoshi, INOUE Tatsuo, YADA Norihisa, HAGIWARA Satoru, MINAMI Yasunori, SAKURAI Toshiharu, NISHIDA Naoshi, KUDO Masatoshi
Kanzo   53(6) 348-350   Jun 2012
【PURPOSE】 Sorafenib is a molecularly-targeted drug, which have been proven survival benefit for advanced hepatocellular carcinoma (HCC). Because of the unique side effects of sorafenib such as hand-foot skin reaction (HFSR), the administration of ...

Conference Activities & Talks

 
The usefulness of helicobacter pylori eradication therapy for the healing of artificial gastric ulcer after endoscopic submucosal dissection for early gastric cancer.
Asian Pacific Digestive Week (APDW) 2010   Sep 2010   Asian Pacific Digestive Week (APDW) 2010
Is the combination therapy of ecabet sodium and proton pump inhibitor (PPI) useful for treating the artificial ulcer after endoscopic submucosal dissection (ESD) treatment of early gastric cancer? : Prospective randomized study.
18th United European Gastroenterology Week (UEGW) 2010   Oct 2010   18th United European Gastroenterology Week (UEGW) 2010
The efficacy of helicobacter pylori eradication therapy for the healing of artificial gastric ulcer after endoscopic submucosal dissection early gastric cancer: Prospective randomized study.
18th United European Gastroenterology Week (UEGW) 2010   Oct 2010   18th United European Gastroenterology Week (UEGW) 2010
Examination of factors of delayed bleeding after endoscopic submucosal dissection (ESD) for gastric tumors.
18th United European Gastroenterology Week (UEGW) 2010   Oct 2010   18th United European Gastroenterology Week (UEGW) 2010
Expression levels of EMT-related genes in hepatocellular carcinoma.
AACR 102th Annual Meeting 2011   Apr 2011   AACR 102th Annual Meeting 2011